Literature DB >> 16538688

Safety and efficacy of staple-mediated femoral arteriotomy closure: results from a randomized multicenter study.

Gary Ansel1, Stephen Yakubov, Christopher Neilsen, David Allie, Robert Stoler, Patrick Hall, Peter Fail, Timothy Sanborn, Ronald P Caputo.   

Abstract

BACKGROUND: Mechanical closure of percutaneous femoral arteriotomies following catheter based procedures remains problematic.
METHODS: The EVS closure device is the first to utilize a staple to effect arteriotomy closure and was compared to manual compression following sheath removal in a 362 patient randomized (2:1 to device) multicenter trial. As pre-specified, one half of the patients underwent coronary intervention.
RESULTS: Time to hemostasis was significantly reduced in the EVS group for both diagnostic (3.3 +/- 2.6 vs. 19.3 +/- 5.7 minutes; p < 0.001) and interventional procedures (5.5 +/- 5.1 vs. 22.3 +/- 9.9 minutes; p < 0.0001). Time to ambulation was similarly reduced in the EVS group following diagnostic (2.4 +/- 3.3 vs. 6.0 +/- 5.2 hours; p < 0.001) and interventional procedures (3.4 +/- 4.5 vs. 7.6 +/- 7.0 hours; p < 0.001). The incidence of major complications was similar between the EVS and manual compression groups at discharge (0.4% vs. 1.7%; p = NS) and at 30 day follow-up (0.4% vs. 2.5%; p = NS).
CONCLUSION: Compared to manual compression, the EVS device provides a safe and effective method of femoral artery closure.

Entities:  

Mesh:

Year:  2006        PMID: 16538688     DOI: 10.1002/ccd.20628

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  4 in total

1.  Initial experience with the AXERA 2 Femoral Access System in neurovascular procedures.

Authors:  Ramesh Grandhi; Nathan T Zwagerman; Xiaoran Zhang; Stephanie H Chen; Ashutosh P Jadhav; Tudor Jovin; Brian T Jankowitz
Journal:  Interv Neuroradiol       Date:  2015-05-26       Impact factor: 1.610

2.  Incidence of delayed angiographic femoral artery complications using the EXOSEAL vascular closure device.

Authors:  Ramesh Grandhi; Xiaoran Zhang; David Panczykowski; Phillip Choi; Christopher T Hunnicutt; Ashutosh P Jadhav; Andrew F Ducruet; Tudor Jovin; Brian Jankowitz
Journal:  Interv Neuroradiol       Date:  2015-05-26       Impact factor: 1.610

3.  Treatment of Angio-Seal® Vascular Closure Device-Induced Acute Femoral Artery Occlusion with SilverHawk® Directional Atherectomy.

Authors:  Rishi Sharma; Karthik Vamanan; Kamal Gupta
Journal:  Cureus       Date:  2016-12-02

Review 4.  Network Meta-analysis of Randomized Trials on the Safety of Vascular Closure Devices for Femoral Arterial Puncture Site Haemostasis.

Authors:  Jun Jiang; Junjie Zou; Hao Ma; Yuanyong Jiao; Hongyu Yang; Xiwei Zhang; Yi Miao
Journal:  Sci Rep       Date:  2015-09-08       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.